<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H93018697C9284B74B6D5009CFFC4AE49" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>117 HR 7586 IH: Securing the Border for Public Health Act of 2022</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2022-04-26</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">117th CONGRESS</congress><session display="yes">2d Session</session><legis-num display="yes">H. R. 7586</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20220426">April 26, 2022</action-date><action-desc><sponsor name-id="L000589">Mrs. Lesko</sponsor> (for herself and <cosponsor name-id="M001215">Mrs. Miller-Meeks</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend title III of the Public Health Service Act to provide for suspension of entries and imports from designated countries to prevent the spread of communicable diseases and import into the United States of certain controlled substances.</official-title></form><legis-body id="HC1F1669BC5BB4344AB6A9FAEF3AFF2E5" style="OLC"> 
<section id="H5443F2AB01BB43AC88C2FB8E28FC5E7D" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Securing the Border for Public Health Act of 2022</short-title></quote>. </text></section> <section id="H4DDFC5259D484D3AA5F7A4FCF51D067D"><enum>2.</enum><header>Suspension of entries and imports from designated countries to prevent spread of communicable diseases and import of certain controlled substances</header><text display-inline="no-display-inline">Section 362 of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/265">42 U.S.C. 265</external-xref>) is amended to read as follows: </text> 
<quoted-block style="OLC" id="H62FBF3C1C2A74C678CE38996A361731E" display-inline="no-display-inline"> 
<section id="HA29D7390DAC04AC799D3C6F8C88548F9"><enum>362.</enum><header>Suspension of entries and imports from designated countries to prevent spread of communicable diseases and import of certain controlled substances</header> 
<subsection id="H82995CB5EF394298AA4DA5C9D702FCC4"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">Whenever the Secretary makes a determination described in subsection (b) with respect to a country, the Secretary, by regulation, shall have the power to prohibit, in whole or in part, for a period of time determined to be necessary by the Secretary, the introduction of persons and property from such countries designated by the Secretary in order to avert the danger described in subsection (b).</text></subsection> <subsection id="HBE6FA5D3A40E49B0B1DCCBA4CCBD345C"><enum>(b)</enum><header>Determination</header><text display-inline="yes-display-inline">A determination made under subsection (a) is a determination by the Secretary that, by reason of the existence of any communicable disease or, after consultation with the Attorney General, certain controlled substances in a foreign country—</text> 
<paragraph id="H49FA11ABE1A6456EA302283E02EBE513"><enum>(1)</enum><text>there is serious danger of the introduction of such disease or substances into the United States; and</text></paragraph> <paragraph id="H281A3E959C804BB59BD6E8B2493906DE"><enum>(2)</enum><text>such danger is so increased by the introduction of persons or property from such country that a suspension of the right to introduce such persons and property is required in the interest of the public health.<italic></italic></text></paragraph></subsection> 
<subsection id="HFABD23305AE042B7A0C78DDB9CFD3B0C"><enum>(c)</enum><header>Definition</header><text display-inline="yes-display-inline">In this section, the term <term>certain controlled substances</term> means—</text> <paragraph id="HE8BCEA6A59DA451B8DEEBE8FB245A065"><enum>(1)</enum><text>a narcotic drug as defined in section 1300.01 of title 21, Code of Federal Regulations (or successor regulations);</text></paragraph> 
<paragraph id="H35BDE398BF77407C83930D4855173CFA"><enum>(2)</enum><text display-inline="yes-display-inline">an opiate as described in section 1308.11(b) or 1308.12(c) of such title (or successor regulations);</text></paragraph> <paragraph id="HB1796AC07ED443248776BF5C1684F671"><enum>(3)</enum><text display-inline="yes-display-inline">an opium derivative as described in section 1308.11(c) of such title (or successor regulations);</text></paragraph> 
<paragraph id="HFF9600E4DDED480393DE0C11D7A42F5D"><enum>(4)</enum><text display-inline="yes-display-inline">a stimulant as described in section 1308.11(f) or 1308.12(d) of such title (or successor regulations); and</text></paragraph> <paragraph id="H5C2B918021DC474E890FC1577FA47E1E"><enum>(5)</enum><text display-inline="yes-display-inline">a fentanyl-related substance as described in section 1308.11(h) of such title (or successor regulations).</text></paragraph></subsection></section><after-quoted-block>.</after-quoted-block></quoted-block> </section> 
</legis-body></bill>

